These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29348537)

  • 1. Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer.
    Kotagiri N; Cooper ML; Rettig M; Egbulefu C; Prior J; Cui G; Karmakar P; Zhou M; Yang X; Sudlow G; Marsala L; Chanswangphuwana C; Lu L; Habimana-Griffin L; Shokeen M; Xu X; Weilbaecher K; Tomasson M; Lanza G; DiPersio JF; Achilefu S
    Nat Commun; 2018 Jan; 9(1):275. PubMed ID: 29348537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stromal cells mediated delivery of photoactive nanoparticles inhibits osteosarcoma growth in vitro and in a murine in vivo ectopic model.
    Lenna S; Bellotti C; Duchi S; Martella E; Columbaro M; Dozza B; Ballestri M; Guerrini A; Sotgiu G; Frisoni T; Cevolani L; Varchi G; Ferrari M; Donati DM; Lucarelli E
    J Exp Clin Cancer Res; 2020 Feb; 39(1):40. PubMed ID: 32087737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing pH-responsive polymeric micelles for drug delivery in a cancer photodynamic therapy model.
    Le Garrec D; Taillefer J; Van Lier JE; Lenaerts V; Leroux JC
    J Drug Target; 2002 Aug; 10(5):429-37. PubMed ID: 12442814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
    Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase-Change Material Packaged within Hollow Copper Sulfide Nanoparticles Carrying Doxorubicin and Chlorin e6 for Fluorescence-Guided Trimodal Therapy of Cancer.
    Li Q; Sun L; Hou M; Chen Q; Yang R; Zhang L; Xu Z; Kang Y; Xue P
    ACS Appl Mater Interfaces; 2019 Jan; 11(1):417-429. PubMed ID: 30537815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Task-Specific Design of Immune-Augmented Nanoplatform to Enable High-Efficiency Tumor Immunotherapy.
    Zhang J; Zhang D; Li Q; Jiang Y; Song A; Li Z; Luan Y
    ACS Appl Mater Interfaces; 2019 Nov; 11(46):42904-42916. PubMed ID: 31657540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases.
    Ross MH; Esser AK; Fox GC; Schmieder AH; Yang X; Hu G; Pan D; Su X; Xu Y; Novack DV; Walsh T; Colditz GA; Lukaszewicz GH; Cordell E; Novack J; Fitzpatrick JAJ; Waning DL; Mohammad KS; Guise TA; Lanza GM; Weilbaecher KN
    Cancer Res; 2017 Nov; 77(22):6299-6312. PubMed ID: 28855208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex Vivo and In Vivo Evaluation of Overexpressed VLA-4 in Multiple Myeloma Using LLP2A Imaging Agents.
    Soodgupta D; Zhou H; Beaino W; Lu L; Rettig M; Snee M; Skeath J; DiPersio JF; Akers WJ; Laforest R; Anderson CJ; Tomasson MH; Shokeen M
    J Nucl Med; 2016 Apr; 57(4):640-5. PubMed ID: 26742713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-carotene-bound albumin nanoparticles modified with chlorin e6 for breast tumor ablation based on photodynamic therapy.
    Phuong PTT; Lee S; Lee C; Seo B; Park S; Oh KT; Lee ES; Choi HG; Shin BS; Youn YS
    Colloids Surf B Biointerfaces; 2018 Nov; 171():123-133. PubMed ID: 30025374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locoregional Confinement and Major Clinical Benefit of
    Séhédic D; Chourpa I; Tétaud C; Griveau A; Loussouarn C; Avril S; Legendre C; Lepareur N; Wion D; Hindré F; Davodeau F; Garcion E
    Theranostics; 2017; 7(18):4517-4536. PubMed ID: 29158842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced anticancer efficacy of snake venom combined with silica nanoparticles in a murine model of human multiple myeloma: molecular targets for cell cycle arrest and apoptosis induction.
    Al-Sadoon MK; Rabah DM; Badr G
    Cell Immunol; 2013; 284(1-2):129-38. PubMed ID: 23973876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiopharmaceutical therapy of 5T33 murine myeloma by sequential treatment with samarium-153 ethylenediaminetetramethylene phosphonate, melphalan, and bone marrow transplantation.
    Turner JH; Claringbold PG; Manning LS; O'Donoghue HL; Berger JD; Glancy RJ
    J Natl Cancer Inst; 1993 Sep; 85(18):1508-13. PubMed ID: 8360933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
    Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
    Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the Tumor Site Recognizable and Dual-Responsive Nanoparticles for Combinational Treatment of the Drug-Resistant Colorectal Cancer.
    Shi Y; Shan S; Li C; Song X; Zhang C; Chen J; You J; Xiong J
    Pharm Res; 2020 Mar; 37(4):72. PubMed ID: 32215748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Delivered and Self-Monitored Chemo-Photodynamic Nanoparticles with Light-Triggered Synergistic Antitumor Therapies by Downregulation of HIF-1α and Depletion of GSH.
    Zhang Z; Wang R; Huang X; Luo R; Xue J; Gao J; Liu W; Liu F; Feng F; Qu W
    ACS Appl Mater Interfaces; 2020 Feb; 12(5):5680-5694. PubMed ID: 31944660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD54 (ICAM-1) has antitumor activity in SCID mice with human myeloma cells.
    Huang YW; Richardson JA; Vitetta ES
    Cancer Res; 1995 Feb; 55(3):610-6. PubMed ID: 7834632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor- and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis.
    Wang H; Zhang F; Wen H; Shi W; Huang Q; Huang Y; Xie J; Li P; Chen J; Qin L; Zhou Y
    J Nanobiotechnology; 2020 Jan; 18(1):8. PubMed ID: 31918714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic activity of the proteasome inhibitor PS-341 with non-myeloablative 153-Sm-EDTMP skeletally targeted radiotherapy in an orthotopic model of multiple myeloma.
    Goel A; Dispenzieri A; Geyer SM; Greiner S; Peng KW; Russell SJ
    Blood; 2006 May; 107(10):4063-70. PubMed ID: 16424391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by α4β1 cytoplasmic-binding proteins.
    Martínez-Moreno M; Leiva M; Aguilera-Montilla N; Sevilla-Movilla S; Isern de Val S; Arellano-Sánchez N; Gutiérrez NC; Maldonado R; Martínez-López J; Buño I; García-Marco JA; Sánchez-Mateos P; Hidalgo A; García-Pardo A; Teixidó J
    Leukemia; 2016 Apr; 30(4):861-72. PubMed ID: 26658839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual pH/reduction-responsive hybrid polymeric micelles for targeted chemo-photothermal combination therapy.
    Zhang L; Qin Y; Zhang Z; Fan F; Huang C; Lu L; Wang H; Jin X; Zhao H; Kong D; Wang C; Sun H; Leng X; Zhu D
    Acta Biomater; 2018 Jul; 75():371-385. PubMed ID: 29777957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.